肺腺癌肝转移与脑转移的突变图谱及演化模式
该研究对26例未经系统治疗的肺腺癌患者(伴肝转移或脑转移)的84份组织与血液样本行全外显子测序,比较配对原发灶与转移灶的突变图谱和演化模式。结果显示TP53和EGFR等驱动突变在原发灶与转移灶间高度一致,肝转移组配对原发灶与转移灶的突变相似性和拷贝数变异相似性均显著高于脑转移组(p=0.019和p=0.035),肝转移符合线性进展模型而脑转移更符合平行进展模型。
要点
- TP53和EGFR等常见驱动突变在配对原发灶与转移灶间高度一致。
- 肝转移组配对原发灶与转移灶的突变及拷贝数变异相似性显著高于脑转移组。
- 肝转移倾向线性进展模型,脑转移更符合平行进展模型。
核心结论
- 肺腺癌肝转移与脑转移的突变图谱和演化模式存在明显差异。
研究设计与样本
- 对26例未经系统治疗的肺腺癌肝转移或脑转移患者的84份组织与血液样本行全外显子测序。
- 比较配对原发灶与转移灶的突变图谱和演化模式。
主要发现
- TP53和EGFR等常见驱动突变在配对原发灶与转移灶间高度一致。
- 三组间肿瘤突变负荷相当。
- 肝转移组配对原发灶与转移灶的突变相似性显著高于脑转移组(p=0.019)。
- 肝转移组配对原发灶与转移灶的拷贝数变异相似性显著高于脑转移组(p=0.035)。
- 系统发育分析显示肝转移播散与配对原发灶遗传相似性更高,且遗传分歧发生较脑转移更晚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A comprehensive genomic analysis of paired primary tumors and their metastatic lesions may provide new insights into the biology of metastatic processes and therefore guide the development of novel strategies for intervention. To date, our knowledge of the genetic divergence and phylogenetic relationships among diverse metastatic lesions from cancer remains limited. METHODS: We performed whole-exome sequencing in 84 tissue and blood samples from 26 patients with lung adenocarcinoma having liver metastases (LiM) or brain metastases (BrM) before any systemic therapy, with the goal to molecularly characterize the metastatic process. Mutational landscape and evolutionary patterns were compared between paired primary lesions (primary lesion of LiM or BrM) and metastases (metastatic site of LiM or BrM). RESULTS: We found that common driver mutations, including TP53 and EGFR, were highly consistent between paired primary and metastatic tumors. Although tumor mutational burden was comparable among groups, the LiM group had significantly higher mutational and copy number variational similarity than the BrM group between paired primary lesions and metastases (p = 0.019 and p = 0.035, respectively). Phylogenetic analysis further revealed that LiM-competent disseminations had a higher level of genetic similarity to their paired primary lesions and were genetically diverged from their primary tumors at a relatively later stage than those of BrM. These results suggest that LiM favorably followed the linear progression model, whereas BrM was more consistent with the parallel progression model. CONCLUSIONS: This study suggests that the mutational landscape and evolutionary pattern was distinctly different between the LiM and BrM of lung adenocarcinoma.
引用
- Jiang T, Fang Z, Tang S, et al. Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma. J Thorac Oncol. 2020. PMID: 33188911. doi:10.1016/j.jtho.2020.10.128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。